Quality Assessments
External Review 2007-2012
- CARIM self-evaluation report 2007-2012
- CARIM self-evaluation report 2007-2012 Addenda
- Report of the External Review Committee 2014
- Response on the report by the Dean FHML 2016
The hybrid ablation treatment developed at Maastricht UMC+ leads to better results in persistent atrial fibrillation than the standard treatment, catheter ablation.
Someone with diabetes has an increased risk of depression, but may be able to limit it by addressing risk factors such as unhealthy diet and high blood pressure. This has emerged from research by scientists at Maastricht UMC+ who analyzed data from nearly 78,000 people.
